238 related articles for article (PubMed ID: 29932287)
1. Risk, pattern and survival impact of second primary tumors in patients with nasopharyngeal carcinoma following definitive intensity-modulated radiotherapy.
Chow JCH; Au KH; Mang OWK; Cheung KM; Ngan RKC
Asia Pac J Clin Oncol; 2019 Feb; 15(1):48-55. PubMed ID: 29932287
[TBL] [Abstract][Full Text] [Related]
2. Second primary cancer after intensity-modulated radiotherapy for nasopharyngeal carcinoma: A territory-wide study by HKNPCSG.
Chow JCH; Tam AHP; Cheung KM; Lee VHF; Chiang CL; Tong M; Wong ECY; Cheung AKW; Chan SPC; Lai JWY; Ngan RKC; Ng WT; Lee AWM; Au KH
Oral Oncol; 2020 Dec; 111():105012. PubMed ID: 32980659
[TBL] [Abstract][Full Text] [Related]
3. The clinical characteristics of secondary primary tumors in patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy: A retrospective analysis.
Zhao W; Lei H; Zhu X; Li L; Qu S; Liang X; Wang X
Medicine (Baltimore); 2016 Nov; 95(45):e5364. PubMed ID: 27828863
[TBL] [Abstract][Full Text] [Related]
4. Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big-Data Intelligence Platform-Based Analysis of 6,377 Long-term Survivors from an Endemic Area Treated with Intensity-Modulated Radiation Therapy during 2003-2013.
Zhang LL; Li GH; Li YY; Qi ZY; Lin AH; Sun Y
Cancer Res Treat; 2019 Jul; 51(3):982-991. PubMed ID: 30309219
[TBL] [Abstract][Full Text] [Related]
5. Risk of second primary malignancies following nasopharyngeal carcinoma in Hong Kong.
Goggins WB; Yu IT; Tse LA; Leung SF; Tung SY; Yu KS
Cancer Causes Control; 2010 Sep; 21(9):1461-6. PubMed ID: 20454843
[TBL] [Abstract][Full Text] [Related]
6. The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.
Kong L; Lu JJ; Hu C; Guo X; Wu Y; Zhang Y
Cancer; 2006 Sep; 107(6):1287-93. PubMed ID: 16909425
[TBL] [Abstract][Full Text] [Related]
7. Increased incidence of tongue cancer after primary radiotherapy for nasopharyngeal carcinoma--the possibility of radiation carcinogenesis.
Teo PM; Chan AT; Leung SF; Chau RM; Yu PK; King WW; Johnson PJ
Eur J Cancer; 1999 Feb; 35(2):219-25. PubMed ID: 10448263
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
[TBL] [Abstract][Full Text] [Related]
9. Postirradiation otitis media with effusion in nasopharyngeal carcinoma patients treated by intensity-modulated radiotherapy.
Hsin CH; Chen TH; Liang KL; Tseng HC; Liu WS
Laryngoscope; 2013 Sep; 123(9):2148-53. PubMed ID: 23835775
[TBL] [Abstract][Full Text] [Related]
10. T4/N2 classification nasopharyngeal carcinoma benefit from concurrent chemotherapy in the era of intensity-modulated radiotherapy.
Xie R; Xia B; Zhang X; Hu W; Zhao R; Xie C; Wang J; Zhang N; Wu S
Oncotarget; 2016 Dec; 7(49):81918-81925. PubMed ID: 27636993
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study.
Huang J; Kong FF; Oei RW; Zhai RP; Hu CS; Ying HM
Radiat Oncol; 2019 Feb; 14(1):31. PubMed ID: 30736809
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic Characteristics and Prognosis of Tongue Squamous Cell Carcinoma in Patients with and without a History of Radiation for Nasopharyngeal Carcinoma: A Matched Case-Control Study.
Zhang P; Zhang L; Liu H; Zhao L; Li Y; Shen JX; Liu Q; Liu MZ; Xi M
Cancer Res Treat; 2017 Jul; 49(3):695-705. PubMed ID: 27737535
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.
Lin YH; Huang TL; Chien CY; Chen HC; Hsu HC; Huang EY; Wang CJ; Huang YJ; Wang YM; Huang CC; Chou SY; Liao KC; Fang FM
Radiat Oncol; 2018 Mar; 13(1):45. PubMed ID: 29554940
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
Su SF; Han F; Zhao C; Chen CY; Xiao WW; Li JX; Lu TX
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):327-33. PubMed ID: 21035959
[TBL] [Abstract][Full Text] [Related]
15. Second malignant tumors in patients with nasopharyngeal carcinoma and their association with Epstein-Barr virus.
Wang CC; Chen ML; Hsu KH; Lee SP; Chen TC; Chang YS; Tsang NM; Hong JH
Int J Cancer; 2000 Jul; 87(2):228-31. PubMed ID: 10861479
[TBL] [Abstract][Full Text] [Related]
16. Systemic chemotherapy followed by locoregional definitive intensity-modulated radiation therapy yields prolonged survival in nasopharyngeal carcinoma patients with distant metastasis at initial diagnosis.
Hu SX; He XH; Dong M; Jia B; Zhou SY; Yang JL; Yang S; Zhang CG; Liu P; Qin Y; Gui L
Med Oncol; 2015 Sep; 32(9):224. PubMed ID: 26219572
[TBL] [Abstract][Full Text] [Related]
17. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.
Huang TL; Chien CY; Tsai WL; Liao KC; Chou SY; Lin HC; Dean Luo S; Lee TF; Lee CH; Fang FM
Head Neck; 2016 Apr; 38 Suppl 1():E1026-32. PubMed ID: 26041548
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up.
Zhang MX; Li J; Shen GP; Zou X; Xu JJ; Jiang R; You R; Hua YJ; Sun Y; Ma J; Hong MH; Chen MY
Eur J Cancer; 2015 Nov; 51(17):2587-95. PubMed ID: 26318726
[TBL] [Abstract][Full Text] [Related]
19. Bone and Soft-Tissue Sarcoma Risk in Long-Term Survivors of Hereditary Retinoblastoma Treated With Radiation.
Kleinerman RA; Schonfeld SJ; Sigel BS; Wong-Siegel JR; Gilbert ES; Abramson DH; Seddon JM; Tucker MA; Morton LM
J Clin Oncol; 2019 Dec; 37(35):3436-3445. PubMed ID: 31622129
[TBL] [Abstract][Full Text] [Related]
20. Comparing Risk for Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer, 2002-2015.
Pithadia KJ; Advani PG; Citrin DE; Bekelman JE; Withrow DR; Berrington de Gonzalez A; Morton LM; Schonfeld SJ
JAMA Oncol; 2023 Aug; 9(8):1119-1123. PubMed ID: 37289449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
